Scarica l'app Stockscreener
21.19
3.11%
0.64
Precedente Chiudi:
$20.55
Aprire:
$20.59
Volume 24 ore:
342.58K
Relative Volume:
3.26
Capitalizzazione di mercato:
$736.33M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+5.69%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$20.00
$22.20
Intervallo di 1 settimana:
$19.65
$25.58
Portata 52W:
$16.59
$25.58
First Tracks Biotherapeutics Inc Stock (TRAX) Company Profile
Nome
First Tracks Biotherapeutics Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare TRAX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TRAX
First Tracks Biotherapeutics Inc
|
21.19 | 736.33M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
First Tracks Biotherapeutics Inc Stock (TRAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-24 | Iniziato | Leerink Partners | Outperform |
| 2026-04-24 | Iniziato | Wedbush | Outperform |
| 2026-04-23 | Iniziato | JP Morgan | Overweight |
| 2026-04-22 | Iniziato | Barclays | Overweight |
| 2026-04-21 | Iniziato | UBS | Buy |
First Tracks Biotherapeutics Inc Borsa (TRAX) Ultime notizie
First Tracks: Huge Cash Reserves Will Not Sustain Testing For Long (TRAX) - Seeking Alpha
This First Tracks Biotherapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday - Sahm
First Tracks Price Target Announced at $54.00/Share by Piper Sandler - Moomoo
First Tracks Initiated at Overweight by Piper Sandler - Moomoo
This First Tracks Biotherapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations F - Benzinga
Piper Sandler initiates First Tracks stock with overweight rating By Investing.com - Investing.com Nigeria
Net income of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics Inc (TRAX) Stock Price, Quote, News & History - Benzinga
TRAX Price History for First Tracks Biotherapeutics Stock - Barchart
Number of employees of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
What is the current Price Target and Forecast for First Tracks Biotherapeutics, Inc. (TRAX) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Earnings Yield (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Total Assets (Quarterly) - Zacks Investment Research
H.C. Wainwright Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $30 - Moomoo
First Tracks Biotherapeutics, Inc. (TRAX) Price To Cash Flow - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Total Expenses (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Total Long Term Debt (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Price To Free Cash Flow - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Net Income (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Cash Equivalents (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Total Liabilities - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Free Cash Flow (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Total Expenses (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Eps Diluted - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Book Value - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Shareholders Equity (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Free Cash Flow (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Cash From Investing (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Revenue (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Enterprise Value - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Gross Profit (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Gross Margin (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Revenue (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Cash From Operations (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Market Cap - Zacks Investment Research
This Micron Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
HC Wainwright Initiates First Tracks Biotherapeutics at Buy - marketscreener.com
H.C. Wainwright initiates First Tracks stock with buy rating By Investing.com - Investing.com Canada
AnaptysBio Completes Spin-Off of First Tracks Biotherapeutics: Key Financial Impacts and Pro Forma Results - Minichart
First Tracks Biotherapeutics, Inc. Financial Statements – NASDAQ:TRAX - TradingView
Price to earnings ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics, Inc. Statistics – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics, Inc. Revenue Breakdown – NASDAQ:TRAX - TradingView
Anaptysbio’s spinout First Tracks hits the slopes - BioWorld News
AnaptysBio rises after completing First Tracks spinoff - MSN
Leerink Partners Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $46 - Moomoo
First Tracks Biotherapeutics, Inc. Dividends – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics, Inc. Income Statement – NASDAQ:TRAX - TradingView
Basic earnings per share (basic EPS) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics Inc Azioni (TRAX) Dati Finanziari
Non sono disponibili dati finanziari per First Tracks Biotherapeutics Inc (TRAX). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):